MILBY RANDY 4
4 · Hillstream BioPharma Inc. · Filed Jan 4, 2023
Insider Transaction Report
Form 4
MILBY RANDY
DirectorCEO
Transactions
- Award
Options (right to purchase)
2023-01-01+621,795→ 621,795 totalExercise: $0.39From: 2023-01-01Exp: 2033-01-01→ Common stock (621,795 underlying)
Footnotes (1)
- [F1]The options were issued pursuant to the Issuer's 2019 Stock Incentive Plan and vested in full upon grant.